NCT02740959View on ClinicalTrials.gov

Effects of PG2 on Fatigue-Related Symptom Clusters

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 8, 2017

Study Completion Date

May 8, 2017

Conditions
Cancer-related Fatigue
Interventions
DRUG

Astragalus Polysaccharides 500 mg

PG2 Injection 500 mg PG2 (500 mg in 500 ml saline), t.i.w. via i.v. infusion for 2.5-3.5 hours over 2 treatment cycles (8 weeks)

DRUG

Astragalus Polysaccharides 250 mg

PG2 Injection 250 mg PG2 (250 mg in 500 ml saline), t.i.w. via i.v. infusion for 2.5-3.5 hours over 2 treatment cycles (8 weeks)

Trial Locations (1)

235

Taipei Medical University -Shung Ho Hospital, Taipei

All Listed Sponsors
lead

Taipei Medical University

OTHER

NCT02740959 - Effects of PG2 on Fatigue-Related Symptom Clusters | Biotech Hunter | Biotech Hunter